Showing posts with label patent protection. Show all posts
Showing posts with label patent protection. Show all posts

Monday, June 26, 2017

Patents can stifle, as well as protect, stifle innovation; Albuquerque Journal, June 26, 2017

Joel Jacobsen, Albuquerque Journal; 

Patents can stifle, as well as protect, stifle innovation


"The absence of patent protection would make it difficult if not impossible for many inventors to profit from their ingenuity. But when a second inventor vastly improves on an original idea, as Curtiss did, isn’t he equally entitled to reap the rewards of his own ingenuity? Even apart from questions of fairness, society benefits from both the original invention and its subsequent improvement. Both types of progress deserve legal protection."

Sunday, June 11, 2017

Disney seeks patent to block 3D-printed knockoffs; Orlando Sentinel, June 9, 2017

Paul Brinkmann, Orlando Sentinel; Disney seeks patent to block 3D-printed knockoffs

"As usual with Disney patents, it’s not clear whether the company actually wants to make the 3D scan-resist figurines, or if it’s just protecting research it has done."

Thursday, July 30, 2015

Patent Protection for Drugs Puts Pressure on U.S. in Trade Talks; New York Times, 7/30/15

Jonathan Weisman, New York Times; Patent Protection for Drugs Puts Pressure on U.S. in Trade Talks:
"“The goal of the pharmaceutical industry is to change the rules internationally, to change global norms with a new monopoly that is cheaper for the companies and stronger,” said Judit Rius Sanjuan, a legal policy adviser for Doctors Without Borders’ medical access campaign, which wants lower-cost drugs on the market faster.
On the other side, Senator Orrin G. Hatch, the Utah Republican who is chairman of the Senate Finance Committee, singled out the next generation of pharmaceuticals, called biologics, and warned on Wednesday that “a strong intellectual-property chapter — including strong patent and regulatory data protections for biologics — is vital to securing congressional support for this trade deal.”
The complexity of the pharmaceutical issues illustrates how difficult it will be to agree on broad trade rules for 12 countries, including giants like the United States and Japan and developing counties like Peru, Malaysia, Vietnam and tiny Brunei. United States negotiators are using novel arguments to secure positions. For instance, they are pushing to mandate open access to the Internet as an antipiracy measure, so Hollywood can use streaming videos to completely cut out the often-copied DVD."